How is PE navigating 2025?
After a turbulent start to 2025, we have revisited our expectations for the PE landscape—and the picture is evolving. While macroeconomic headwinds, rising consumer and business credit delinquencies, and federal budget imbalances pose challenges, PE firms remain resilient and strategically poised for opportunities ahead.
One bright spot is the healthcare sector, underscored by Sycamore Partners’ blockbuster $23.7 billion take-private of Walgreens Boots Alliance—the largest healthcare PE take-private since the global financial crisis. This highlights renewed optimism driven by easing regulatory pressures. Meanwhile, despite policy shifts and tariff uncertainties under the new Trump administration, GPs are actively deploying capital, ready to leverage market dislocations and eager sellers.
Dive into our Q1 2025 US PE Pulse analyst note to understand how firms navigate risks and uncover attractive opportunities in today’s dynamic market environment.
Table of contents
| Key takeaways | 1 |
| Early signals amid policy shifts | 2 |
| Taking the pulse of GP sentiment | 3 |
| Risks and headwinds for 2025 | 4 |